A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease

Clinical trial NCT04647383 · COMPLETED

Trial details

NCT number: NCT04647383
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sleep Apnea, Obstructive Pulmonary Disease, Chronic Obstructive Respiration Disorders

Start date: 2021-01-06
Primary completion: 2022-02-10
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.